• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无义突变型肌营养不良症的诊断途径:三级中心的回顾性经验

Diagnostic Pathway to Nonsense Mutation Dystrophinopathy: A Tertiary-Center, Retrospective Experience.

作者信息

Ardıçlı Didem, Haliloğlu Goknur, Alikaşifoğlu Mehmet, Topaloğlu Haluk

机构信息

Department of Pediatric Neurology, Hacettepe University Children's Hospital, Ankara, Turkey.

Department of Medical Genetics, Hacettepe University Children's Hospital, Ankara, Turkey.

出版信息

Neuropediatrics. 2019 Feb;50(1):41-45. doi: 10.1055/s-0038-1675626. Epub 2018 Nov 19.

DOI:10.1055/s-0038-1675626
PMID:30453357
Abstract

Up to 15% of Duchenne's muscular dystrophy (DMD) is caused by nonsense mutations (nm-DMD). In this study, we aimed to evaluate the age at diagnosis, presentations, and diagnostic approach in 43 nm-DMD boys. The mean age at presentation and diagnosis was 3 years and 4 years, respectively. Presenting signs or symptoms were asymptomatic creatine kinase (CK) elevation (40%), muscle weakness (30%), motor delay (18%), and walking difficulties (12%). Multiplex polymerase chain reaction (PCR) of the most commonly deleted exons were negative ( = 17), and muscle biopsy was consistent with dystrophinopathy ( = 24). In all patients, multiplex ligation-dependent probe amplification (MLPA) followed by direct sequencing of all exons, revealed nm-DMD. Mean age at genetic diagnosis was 6 years 8 months. Patients were evaluated in two-time periods, between 2006 and 2011 (Group I:  = 10) and 2011 and 2017 (Group II:  = 33). The mean age at diagnosis/genetic confirmation in Group I and in Group II was 3 years 9 months/10 years, and 4 years 1 month/5 years 9 months, respectively. Most frequently performed first step diagnostic tests in Group I and Group II were muscle biopsy and MLPA.Our study reflects the change in the age at genetic diagnosis and diagnostic approach to nm-DMD depending on the advances and availability of genetic testing.

摘要

高达15%的杜氏肌营养不良症(DMD)由无义突变(nm-DMD)引起。在本研究中,我们旨在评估43例nm-DMD男孩的诊断年龄、临床表现及诊断方法。出现症状和诊断时的平均年龄分别为3岁和4岁。出现的体征或症状有无症状性肌酸激酶(CK)升高(40%)、肌肉无力(30%)、运动发育迟缓(18%)和行走困难(12%)。最常见缺失外显子的多重聚合酶链反应(PCR)结果为阴性(n = 17),肌肉活检结果与肌营养不良蛋白病一致(n = 24)。在所有患者中,多重连接依赖探针扩增(MLPA)随后对所有外显子进行直接测序,均发现了nm-DMD。基因诊断的平均年龄为6岁8个月。患者在两个时间段接受评估,2006年至2011年(第一组:n = 10)和2011年至2017年(第二组:n = 33)。第一组和第二组诊断/基因确认的平均年龄分别为3岁9个月/10岁和4岁1个月/5岁9个月。第一组和第二组最常进行的第一步诊断测试分别是肌肉活检和MLPA。我们的研究反映了根据基因检测技术的进步和可及性,nm-DMD基因诊断年龄和诊断方法的变化。

相似文献

1
Diagnostic Pathway to Nonsense Mutation Dystrophinopathy: A Tertiary-Center, Retrospective Experience.无义突变型肌营养不良症的诊断途径:三级中心的回顾性经验
Neuropediatrics. 2019 Feb;50(1):41-45. doi: 10.1055/s-0038-1675626. Epub 2018 Nov 19.
2
Molecular and Histopathological Characterization of Patients Presenting with the Duchenne Muscular Dystrophy Phenotype in a Tertiary Care Center in Southern India.印度南部一家三级护理中心具有杜氏肌营养不良表型患者的分子和组织病理学特征。
Indian Pediatr. 2019 Jul 15;56(7):556-559.
3
A comparative study of mPCR, MLPA, and muscle biopsy results in a cohort of children with Duchenne muscular dystrophy: a first study.对一组杜氏肌营养不良症患儿进行的多重聚合酶链反应(mPCR)、多重连接探针扩增技术(MLPA)和肌肉活检结果的比较研究:一项初步研究。
Neurol India. 2015 Jan-Feb;63(1):58-62. doi: 10.4103/0028-3886.152635.
4
Whole-Exome Sequencing Identifies Small Mutations in Pakistani Muscular Dystrophy Patients.全外显子组测序鉴定巴基斯坦肌肉萎缩症患者的小突变。
Genet Test Mol Biomarkers. 2021 Mar;25(3):218-226. doi: 10.1089/gtmb.2020.0246.
5
Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis.应用多重连接依赖性探针扩增(MLPA)技术进行杜氏肌营养不良症(DMD)基因突变分析。
Indian J Med Res. 2010 Sep;132:303-11.
6
Analysis of dystrophin gene in Iranian Duchenne and Becker muscular dystrophies patients and identification of a novel mutation.伊朗杜兴氏和贝克氏肌肉营养不良症患者的肌营养不良蛋白基因分析及一种新突变的鉴定。
Neurol Sci. 2015 Nov;36(11):2011-7. doi: 10.1007/s10072-015-2290-2. Epub 2015 Jun 17.
7
Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.在沙特社区的杜氏肌营养不良症患者中,对肌营养不良蛋白基因中外显子重排和移码的分子特征进行研究。
Hum Genomics. 2018 Apr 10;12(1):18. doi: 10.1186/s40246-018-0152-8.
8
A novel point mutation affecting Asn76 of dystrophin protein leads to dystrophinopathy.一种影响抗肌萎缩蛋白蛋白中天冬酰胺 76 位的新型点突变可导致抗肌萎缩蛋白病。
Neuromuscul Disord. 2018 Feb;28(2):129-136. doi: 10.1016/j.nmd.2017.12.003. Epub 2017 Dec 7.
9
EVALUATION OF MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION AS A TOOL FOR DIAGNOSIS AND CARRIER DETECTION IN FAMILIES WITH A DYSTROPHINOPATHY.多重连接依赖探针扩增技术作为诊断和检测肌营养不良症家族携带者的工具的评估
Genet Couns. 2016;27(4):449-460.
10
Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan.日本肌营养不良症的基因诊断综合分析。
Orphanet J Rare Dis. 2017 Aug 31;12(1):149. doi: 10.1186/s13023-017-0703-4.

引用本文的文献

1
Recoding of Nonsense Mutation as a Pharmacological Strategy.将无义突变重新编码作为一种药理学策略。
Biomedicines. 2023 Feb 22;11(3):659. doi: 10.3390/biomedicines11030659.
2
Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems.靶向无义突变:优化 1,2,4-恶二唑 TRIDs 以拯救囊性纤维化细胞模型系统中的 CFTR 表达和功能。
Int J Mol Sci. 2020 Sep 3;21(17):6420. doi: 10.3390/ijms21176420.
3
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs).
对抗无意义突变策略:恶二唑类作为翻译通读诱导药物(TRIDs)。
Int J Mol Sci. 2019 Jul 6;20(13):3329. doi: 10.3390/ijms20133329.